ALT FY 2023 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$426,000+726.5% YoY

Gross Profit

$426,000100.0% margin

Operating Income

-$96M-22518.5% margin

Net Income

-$88M-20762.2% margin

EPS (Diluted)

$-1.66

Cash Flow

Operating Cash Flow

-$76M

Free Cash Flow

-$76M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$211M

Total Liabilities

$17M

Stockholders' Equity

$194M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$426,000	-$68,000	+726.5%
Gross Profit	$426,000	-$68,000	+726.5%
Operating Income	-$96M	-$88M	-9.3%
Net Income	-$88M	-$85M	-4.4%